{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:15:24Z","timestamp":1794608124769,"version":"4.9.1"},"reference-count":45,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"unspecified","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Unitaid Adherence Support Coalition to End TB","award":["20193\u20133-ASCENT"],"award-info":[{"award-number":["20193\u20133-ASCENT"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2024,11,18]]},"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Digital adherence technologies (DATs) with associated differentiated care are potential tools to improve tuberculosis (TB) treatment outcomes and reduce associated costs for both patients and healthcare providers. However, the balance between epidemiological and economic benefits remains unclear. Here, we used data from the ASCENT trial to estimate the potential long-term epidemiological and economic impact of DAT interventions in Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed a compartmental transmission model for TB, calibrated to Ethiopia and parameterised with patient and provider costs. We compared the epidemiological and economic impact of two DAT interventions, a digital pillbox and medication labels, to the current standard of care, assuming each was introduced at scale in 2023. We projected long-term TB incidence, mortality and costs to 2035 and conducted a threshold analysis to identify the maximum possible epidemiological impact of a DAT intervention by assuming 100% treatment completion for patients on DAT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>We estimated small and uncertain epidemiological benefits of the pillbox intervention compared with the standard of care in Ethiopia, with a difference of \u22120.4% (95% uncertainty interval (UI) \u22121.1%; +2.0%) incident TB episodes and \u22120.7% (95% UI \u22122.2%; +3.6%) TB deaths. However, our analysis also found large total provider and patient cost savings (US$163 (95% UI US$118; US$211) and US$3 (95%UI: US$1; US$5), respectively, over 2023\u20132035), translating to a 50.2% (95% UI 35.9%; 65.2%) reduction in total cost of treatment. Results were similar for the medication label intervention. The maximum possible epidemiological impact a theoretical DAT intervention could achieve over the same timescale would be a 3% (95% UI 1.4%; 5.5%) reduction in incident TB and an 8.2% (95% UI 4.4%; 12.8%) reduction in TB deaths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>DAT interventions, while showing limited epidemiological impact, could substantially reduce TB treatment costs for both patients and the healthcare provider.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgh-2024-016997","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T20:29:06Z","timestamp":1733776146000},"page":"e016997","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Modelling the epidemiological and economic impact of digital adherence technologies with differentiated care for tuberculosis treatment in Ethiopia"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2392-6271","authenticated-orcid":false,"given":"Lara","family":"Gosc\u00e9","sequence":"first","affiliation":[{"name":"TB modelling Group, TB centre, London School of Hygiene & Tropical Medicine Faculty of Epidemiology and Public Health, London, UK"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health, London, UK"},{"name":"Institute for Global Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7805-3191","authenticated-orcid":false,"given":"Amare Worku","family":"Tadesse","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health, London, UK"},{"name":"Reproductive Health, Population and Nutrition, Addis Continental Institute of Public Health, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Foster","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"van Kalmthout","sequence":"additional","affiliation":[{"name":"KNCV Tuberculosis Foundation, Den Haag, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Job van","family":"Rest","sequence":"additional","affiliation":[{"name":"KNCV Tuberculosis Foundation, Den Haag, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jense","family":"van der Wal","sequence":"additional","affiliation":[{"name":"KNCV Tuberculosis Foundation, Den Haag, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6154-3517","authenticated-orcid":false,"given":"Martin J","family":"Harker","sequence":"additional","affiliation":[{"name":"TB modelling Group, TB centre, London School of Hygiene & Tropical Medicine Faculty of Epidemiology and Public Health, London, UK"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7667-2108","authenticated-orcid":false,"given":"Norma","family":"Madden","sequence":"additional","affiliation":[{"name":"KNCV Tuberculosis Foundation, Den Haag, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tofik","family":"Abdurhman","sequence":"additional","affiliation":[{"name":"KNCV Tuberculosis Foundation, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demekech","family":"Gadissa","sequence":"additional","affiliation":[{"name":"KNCV Tuberculosis Foundation, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Bedru","sequence":"additional","affiliation":[{"name":"KNCV Tuberculosis Foundation, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanyaradzwa N","family":"Dube","sequence":"additional","affiliation":[{"name":"The Aurum Institute, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Alacapa","sequence":"additional","affiliation":[{"name":"7KNCV Tuberculosis Foundation, Makati City, Metro Manila, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mganga","sequence":"additional","affiliation":[{"name":"KNCV Tuberculosis Foundation, Dar es Salaam, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Deyanova","sequence":"additional","affiliation":[{"name":"Program for Appropriate Technology in Health (PATH), Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"Charalambous","sequence":"additional","affiliation":[{"name":"The Aurum Institute, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taye","family":"Letta","sequence":"additional","affiliation":[{"name":"Ethiopian Ministry of Health, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Degu","family":"Jerene","sequence":"additional","affiliation":[{"name":"KNCV Tuberculosis Foundation, Den Haag, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4410-6635","authenticated-orcid":false,"given":"Richard","family":"White","sequence":"additional","affiliation":[{"name":"TB modelling Group, TB centre, London School of Hygiene & Tropical Medicine Faculty of Epidemiology and Public Health, London, UK"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6524-3754","authenticated-orcid":false,"given":"Katherine L","family":"Fielding","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-7467","authenticated-orcid":false,"given":"Rein MGJ","family":"Houben","sequence":"additional","affiliation":[{"name":"TB modelling Group, TB centre, London School of Hygiene & Tropical Medicine Faculty of Epidemiology and Public Health, London, UK"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6199-0931","authenticated-orcid":false,"given":"Christopher Finn","family":"McQuaid","sequence":"additional","affiliation":[{"name":"TB modelling Group, TB centre, London School of Hygiene & Tropical Medicine Faculty of Epidemiology and Public Health, London, UK"},{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"key":"2025073014075469000_9.12.e016997.1","unstructured":"World Health Organisation . Tuberculosis: key facts. 2023. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis"},{"key":"2025073014075469000_9.12.e016997.2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00309102"},{"key":"2025073014075469000_9.12.e016997.3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-12-1"},{"key":"2025073014075469000_9.12.e016997.4","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-015-0279-6"},{"key":"2025073014075469000_9.12.e016997.5","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17155626","article-title":"Factors Influencing Patient Adherence to Tuberculosis Treatment in Ethiopia: A Literature Review","volume":"17","author":"Nezenega","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2025073014075469000_9.12.e016997.6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-1"},{"key":"2025073014075469000_9.12.e016997.7","unstructured":"World Health Organisation . Global tuberculosis report 2022. World Health Organisation; 2022. Available: https:\/\/apps.who.int\/iris\/handle\/10665\/363752"},{"key":"2025073014075469000_9.12.e016997.8","unstructured":"World Health Organisation . Global tuberculosis report 2021. World Health Organization; 2021. Available: https:\/\/apps.who.int\/iris\/handle\/10665\/346387"},{"key":"2025073014075469000_9.12.e016997.9","unstructured":"Ethiopia Ministry of Health . Ethiopia national health accounts report 2019-20. 2022."},{"key":"2025073014075469000_9.12.e016997.10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5588\/pha.24.0006","article-title":"TB-related catastrophic costs in Ethiopia","volume":"14","author":"Deribew","year":"2024","journal-title":"Public Health Action"},{"key":"2025073014075469000_9.12.e016997.11","unstructured":"Ministry of Health Ethiopia . Tuberculosis and leprosy national strategic plan (tbl-nsp) July 2021 \u2013 June 2026. 2020."},{"key":"2025073014075469000_9.12.e016997.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-001018","article-title":"Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities","volume":"3","author":"Subbaraman","year":"2018","journal-title":"BMJ Glob Health"},{"key":"2025073014075469000_9.12.e016997.13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5588\/ijtld.22.0500","article-title":"The effect of medication event reminder monitoring on treatment adherence of TB patients","volume":"27","author":"Velen","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025073014075469000_9.12.e016997.14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.44210","article-title":"In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence: A Randomized Noninferiority Trial","volume":"5","author":"Burzynski","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025073014075469000_9.12.e016997.15","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1016\/S2214-109X(23)00068-2","article-title":"Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial","volume":"11","author":"Liu","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2025073014075469000_9.12.e016997.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0224-2"},{"key":"2025073014075469000_9.12.e016997.17","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.19.0472"},{"key":"2025073014075469000_9.12.e016997.18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01596-2017","article-title":"The impact of digital health technologies on tuberculosis treatment: a systematic review","volume":"51","author":"Ngwatu","year":"2018","journal-title":"Eur Respir J"},{"key":"2025073014075469000_9.12.e016997.19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5588\/ijtld.21.0070","article-title":"Digital adherence technology for TB: focus on livelihoods as well as lives","volume":"25","author":"McQuaid","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025073014075469000_9.12.e016997.20","doi-asserted-by":"crossref","DOI":"10.2196\/33062","article-title":"Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials","volume":"24","author":"Ridho","year":"2022","journal-title":"J Med Internet Res"},{"key":"2025073014075469000_9.12.e016997.21","doi-asserted-by":"crossref","unstructured":"Mohamed MS , Zary M , Kafie C , et al . The impact of digital adherence technologies on health outcomes in tuberculosis: a systematic review and meta-analysis. medRxiv [Preprint]. doi:10.1101\/2024.01.31.24302115","DOI":"10.1101\/2024.01.31.24302115"},{"key":"2025073014075469000_9.12.e016997.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1806550"},{"key":"2025073014075469000_9.12.e016997.23","doi-asserted-by":"crossref","unstructured":"Wei X , Hicks JP , Zhang Z , et al . Effectiveness of a comprehensive package based on electronic medication monitors at improving treatment outcomes among tuberculosis patients in tibet: a multi-centre randomised controlled trial. ERS Congress 2024 abstracts; 2024 doi:10.1183\/13993003.congress-2024.PA2359","DOI":"10.1183\/13993003.congress-2024.PA2359"},{"key":"2025073014075469000_9.12.e016997.24","article-title":"TextTB: A Mixed Method Pilot Study Evaluating Acceptance, Feasibility, and Exploring Initial Efficacy of a Text Messaging Intervention to Support TB Treatment Adherence","volume":"2013","author":"Iribarren","year":"2013","journal-title":"Tuberc Res Treat"},{"key":"2025073014075469000_9.12.e016997.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003628","article-title":"Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda","volume":"18","author":"Cattamanchi","year":"2021","journal-title":"PLoS Med"},{"key":"2025073014075469000_9.12.e016997.26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1186\/s12889-018-5502-x","article-title":"SMS reminders to improve adherence and cure of tuberculosis patients in Cameroon (TB-SMS Cameroon): a randomised controlled trial","volume":"18","author":"Bediang","year":"2018","journal-title":"BMC Public Health"},{"key":"2025073014075469000_9.12.e016997.27","doi-asserted-by":"publisher","DOI":"10.7326\/M17-1150"},{"key":"2025073014075469000_9.12.e016997.28","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01488-2017","article-title":"The effect of text messaging on latent tuberculosis treatment adherence: a randomised controlled trial","volume":"51","author":"Johnston","year":"2018","journal-title":"Eur Respir J"},{"key":"2025073014075469000_9.12.e016997.29","article-title":"Mobile health to improve adherence to tuberculosis treatment in Khartoum state, Sudan","volume":"10","author":"Ali","year":"2019","journal-title":"J Public Health Afr"},{"key":"2025073014075469000_9.12.e016997.30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.30509","article-title":"Effect of Digital Medication Event Reminder and Monitor-Observed Therapy vs Standard Directly Observed Therapy on Health-Related Quality of Life and Catastrophic Costs in Patients With Tuberculosis: A Secondary Analysis of a Randomized Clinical Trial","volume":"5","author":"Manyazewal","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025073014075469000_9.12.e016997.31","first-page":"924","article-title":"Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda","volume":"25","author":"Thompson","year":"2022","journal-title":"V Health"},{"key":"2025073014075469000_9.12.e016997.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267292","article-title":"Cost-effectiveness of a medication event monitoring system for tuberculosis management in Morocco","volume":"17","author":"Yang","year":"2022","journal-title":"PLoS ONE"},{"key":"2025073014075469000_9.12.e016997.33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235572","article-title":"Drones and digital adherence monitoring for community-based tuberculosis control in remote Madagascar: A cost-effectiveness analysis","volume":"15","author":"Bahrainwala","year":"2020","journal-title":"PLoS One"},{"key":"2025073014075469000_9.12.e016997.34","doi-asserted-by":"crossref","unstructured":"Nsengiyumva NP , Khan A , Gler MMaTS , et al . Costs of digital adherence technologies for tuberculosis treatment support. medRxiv [Preprint]. doi:10.1101\/2023.03.18.23287420","DOI":"10.1101\/2023.03.18.23287420"},{"key":"2025073014075469000_9.12.e016997.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-06833-x","article-title":"Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial","volume":"21","author":"Tadesse","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2025073014075469000_9.12.e016997.36","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-023-07289-x","article-title":"Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: protocol and analysis plan for the health economics component of a cluster randomised trial","volume":"24","author":"Foster","year":"2023","journal-title":"Trials"},{"key":"2025073014075469000_9.12.e016997.37","doi-asserted-by":"crossref","unstructured":"Tadesse AW , Sahile M , Foster N , et al . Cluster-randomized trial of digital adherence technologies and differentiated care to reduce poor end-of-treatment outcomes and recurrence among adults with drug-sensitive pulmonary tb in Ethiopia. medRxiv [Preprint]. doi:10.1101\/2024.05.09.24307117","DOI":"10.1101\/2024.05.09.24307117"},{"key":"2025073014075469000_9.12.e016997.38","doi-asserted-by":"crossref","unstructured":"Foster N , Tadesse AW , Belachew M , et al . Equity, cost and disability adjusted life years of tuberculosis treatment supported by digital adherence technologies and differentiated care in ethiopia: a trial-based distributional cost-effectiveness analysis. medRxiv [Preprint]. doi:10.1101\/2024.07.28.24310767","DOI":"10.1101\/2024.07.28.24310767"},{"key":"2025073014075469000_9.12.e016997.39","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.13.0417"},{"key":"2025073014075469000_9.12.e016997.40","unstructured":"World Health Organisation . Global tuberculosis programme. 2022. Available: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/data"},{"key":"2025073014075469000_9.12.e016997.41","unstructured":"Iskauskas A , Vernon I , Goldstein M , et al . Emulation and History Matching using the hmer Package. 2022;220905265."},{"key":"2025073014075469000_9.12.e016997.42","doi-asserted-by":"crossref","unstructured":"Scarponi D , Iskauskas A , Clark RA , et al . Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package - hmer. Epidemics 2023;43. doi:10.1016\/j.epidem.2023.100678","DOI":"10.1016\/j.epidem.2023.100678"},{"key":"2025073014075469000_9.12.e016997.43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068685","article-title":"Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries: a pragmatic cluster randomised trial protocol","volume":"13","author":"Jerene","year":"2023","journal-title":"BMJ Open"},{"key":"2025073014075469000_9.12.e016997.44","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000964","article-title":"Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data","volume":"3","author":"Ochalek","year":"2018","journal-title":"BMJ Glob Health"},{"key":"2025073014075469000_9.12.e016997.45","doi-asserted-by":"crossref","first-page":"e816","DOI":"10.1016\/S2214-109X(16)30265-0","article-title":"Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models","volume":"4","author":"Menzies","year":"2016","journal-title":"Lancet Glob Health"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2024-016997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T21:08:08Z","timestamp":1753909688000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2024-016997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,9]]},"published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1136\/bmjgh-2024-016997"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2024-016997","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}